국내 주의력결핍 과잉행동 장애 아동 및 청소년의 약물요법 패턴 및 지속성

키워드

참고문헌 (52)

1. "Diagnostic and statistical manual of mental disorders (<TEX>$DSM-5^{(R)}$</TEX>), American Psychiatric Pub"[URL]
2. Subcommittee on Attention-Deficit, "Hyperactivity D", ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit, Pediatrics, pp.2011, 128[DOI]
3. Polanczyk G, "The worldwide prevalence of ADHD: a systematic review and metaregression analysis", Am J Psychiatry, 164, pp.942~948 (2007)[DOI]
4. Polanczyk GV, "ADHD prevalence estimates across three decades: an updated systematic review and metaregression analysis", Int J Epidemiol, 43, pp.434~442 (2014)[DOI]
5. Willcutt EG, "The prevalence of DSM-IV attention-deficit", hyperactivity disorder: a meta-analytic review, 2012, pp.9, 490~499
6. Faraone SV, "The worldwide prevalence of ADHD: is it an American condition?", World Psychiatry, 2, pp.104~113 (2003)
7. 양수진, "주의력 결핍 과잉 행동 장애의 유병률과 관련 인자 : 서울시 학교 정신보건 사업", 신경정신의학, 45(1), pp.69~76 (2006), 대한신경정신의학회
8. Cho S-C, "Prevalence of disruptive behavior disorders", J Korean Acad Child Adolesc Psychiatry, 5, pp.141~149 (1994)
9. Kim JY, "An epidemiological study of attention-deficits hyperactivity disorder and learning disabilities in a rural area", J Korean Neuropsychiatr Assoc, 38, pp.784~793 (1999)
10. Reports of epidemiological study, "Center SCaAMH", ~ (2005)
11. Yoon Huh, "A Comparison of Comorbidity and Psychological Outcomes in Children and Adolescents with Attention-Deficit", Hyperactivity Disorder, 2011, pp.8(2), 95~101[DOI]
12. Ambrosini PJ, "Attention deficit hyperactivity disorder characteristics: II. Clinical correlates of irritable mood", J Affect Disord, 145, pp.70~76 (2013)[DOI]
13. Bussing R, "Adolescent outcomes of childhood attention-deficit", hyperactivity disorder in a diverse community sample, 2010, pp.49, 595~605
14. Jensen PS, "Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers", J Dev Behav Pediatr, 22, pp.60~73 (2001)[DOI]
15. Larson K, "Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007", Pediatrics, 127, pp.462~470 (2011)[DOI]
16. Group MC, "A 14-month randomized clinical trial of treatment strategies for attention-deficit", hyperactivity disorder, 1999, pp.56, 1073~1086
17. Pliszka SR, "Comorbidity of attention-deficit", hyperactivity disorder with psychiatric disorder: an overview, 1998, pp.59, 50~58
18. Biederman J, "Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder", Int J Neuropsychopharmacol, 7, pp.77~97 (2004)[DOI]
19. Briars L, "A Review of Pharmacological Management of Attention-Deficit", Hyperactivity Disorder, 2016, pp.21, 192~206
20. Spencer T, "Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle", J Am Acad Child Adolesc Psychiatry, 35, pp.409~432 (1996)[DOI]
21. Meijer WM, "Current issues around the pharmacotherapy of ADHD in children and adults", Pharm World Sci, 31, pp.509~516 (2009)[DOI]
22. Gajria K, "Adherence, persistence, and medication discontinuation in patients with attention-deficit", hyperactivity disorder - a systematic literature review, 2014, pp.10, 1543~1569
23. Lara C, "Childhood predictors of adult ADHD: results from the WHO World Mental Health (WMH) Survey Initiative", Biol Psychiatry, 65, pp.46~54 (2009)[DOI]
24. McCarthy S, "Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults", Br J Psychiatry, 194, pp.273~277 (2009)[DOI]
25. McCarthy S, "Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence", BMC Psychiatry, 12, pp.219~ (2012)[DOI]
26. Kim L, "A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples", Epidemiol Health, 36, pp.e2014008~ (2014)
27. Ahmed R, "Attention-deficit", hyperactivity disorder: an update on medication adherence and persistence in children, adolescents and adults, 2013, pp.13, 791~815
28. Wang LJ, "Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan", PLoS One, 11, pp.e0161061~ (2016)[DOI]
29. Ho PM, "Medication Adherence. Its Importance in Cardiovascular Outcomes", Circulation, 119, pp.3028~3035 (2009)[DOI]
30. Halpern MT, "Recommendations for Evaluating Compliance and Persistence With Hypertension Therapy Using Retrospective Data", Hypertension, 47, pp.1039~1048 (2006)[DOI]
31. Ayaz M, "Medication Persistence in Turkish Children and Adolescents with Attention-Deficit", Hyperactivity Disorder, 2014, pp.24, 442~447
32. Winterstein AG, "Utilization of pharmacologic treatment in youths with attention deficit", hyperactivity disorder in Medicaid database, 2008, pp.42, 24~31
33. Garbe E, "Drug treatment patterns of attention-deficit", hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study, 2012, pp.22, 452~458
34. McCarthy S, "Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence", BMC psychiatry, 12, pp.1~ (2012)[DOI]
35. Atzori P, "Predictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-month naturalistic study", J Child Adolesc Psychopharmacol, 19, pp.673~681 (2009)[DOI]
36. Park J, "Comorbidity and Factors Affecting Treatment Non-Persistence in ADHD", J Atten Disord (2015)
37. Miller VA, "Decision-making competence and adherence to treatment in adolescents with diabetes", J Pediatr Psychol, 32, pp.178~88 (2007)
38. Chacko A, "Improving medication adherence in chronic pediatric health conditions: a focus on ADHD in youth", Curr Pharm Des, 16, pp.2416~2423 (2010)[DOI]
39. van den Ban E, "Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands", Atten Defic Hyperact Disord, 2, pp.213~220 (2010)[DOI]
40. Atzori P, "Predictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-month naturalistic study", J Child Adolesc Psychopharmacol, 19, pp.673~681 (2009)[DOI]
41. Baucom KJ, "Depressive symptoms, daily stress, and adherence in late adolescents with type 1 diabetes", Health Psychol, 34, pp.522~ (2015)[DOI]
42. DiMatteo MR, "Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence", Arch Intern Med, 160, pp.2101~2107 (2000)[DOI]
43. Wing RR, "The role of adherence in mediating the relationship between depression and health outcomes", J Psychosom Res, 53, pp.877~881 (2002)[DOI]
44. Raman SR, "An observational study of pharmacological treatment in primary care of children with ADHD in the United Kingdom", Psychiatr Serv, 66, pp.617~624 (2015)[DOI]
45. Lawson KA, "Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program", Clin Ther, 34, pp.944~956 (2012)[DOI]
46. 방수영, "Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit", Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database, 2016, pp.31(8), 1284~1291[DOI]
47. Gau SS-F, "An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit", hyperactivity disorder in Taiwan, 2006, pp.16, 441~455
48. Steele M, "A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder", Can J Clin Pharmacol, 13, pp.e50~e62 (2006)
49. Charach A, "Enhancing ADHD medication adherence: challenges and opportunities", Curr Psychiatry Rep, 15, pp.371~ (2013)[DOI]
50. Rezaei G, "Comparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysis", Med J Islam Repub Iran, 30, pp.325~ (2016)
51. Lawson KA, "Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analy- sis of data from the Texas Medicaid program", Clin Ther, 34, pp.944~956 (2012)[DOI]
52. Gajria K, "Adherence, persistence, and medication discontinuation in patients with attention-deficit", hyperactivity disorder-a systematic literature review, 2014, pp.10, 1543~1569

관련 논문AI추천